JP2025516484A5 - - Google Patents

Info

Publication number
JP2025516484A5
JP2025516484A5 JP2024563496A JP2024563496A JP2025516484A5 JP 2025516484 A5 JP2025516484 A5 JP 2025516484A5 JP 2024563496 A JP2024563496 A JP 2024563496A JP 2024563496 A JP2024563496 A JP 2024563496A JP 2025516484 A5 JP2025516484 A5 JP 2025516484A5
Authority
JP
Japan
Prior art keywords
protein
lentiviral
rna
population
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024563496A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025516484A (ja
Filing date
Publication date
Priority claimed from EP22170965.2A external-priority patent/EP4269603A1/en
Application filed filed Critical
Publication of JP2025516484A publication Critical patent/JP2025516484A/ja
Publication of JP2025516484A5 publication Critical patent/JP2025516484A5/ja
Pending legal-status Critical Current

Links

JP2024563496A 2022-04-29 2023-04-28 レンチウイルスベクターによる標的ｄｎａ組み込みおよびその使用 Pending JP2025516484A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22170965.2 2022-04-29
EP22170965.2A EP4269603A1 (en) 2022-04-29 2022-04-29 Targeted dna integration with lentiviral vectors and uses thereof
PCT/EP2023/061394 WO2023209227A1 (en) 2022-04-29 2023-04-28 Targeted dna integration with lentiviral vectors and uses thereof

Publications (2)

Publication Number Publication Date
JP2025516484A JP2025516484A (ja) 2025-05-30
JP2025516484A5 true JP2025516484A5 (https=) 2026-04-10

Family

ID=81750599

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024563496A Pending JP2025516484A (ja) 2022-04-29 2023-04-28 レンチウイルスベクターによる標的ｄｎａ組み込みおよびその使用

Country Status (5)

Country Link
US (1) US20250288689A1 (https=)
EP (2) EP4269603A1 (https=)
JP (1) JP2025516484A (https=)
CN (1) CN119278267A (https=)
WO (1) WO2023209227A1 (https=)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20260055430A1 (en) * 2021-03-08 2026-02-26 Flagship Pioneering Innovations Vi, Llc Lentivirus with altered integrase activity

Similar Documents

Publication Publication Date Title
US11149259B2 (en) CRISPR-Cas systems and methods for altering expression of gene products, structural information and inducible modular Cas enzymes
US12037611B2 (en) Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods
KR20160089530A (ko) Ｈｂｖ 및 바이러스 질병 및 질환을 위한 ｃｒｉｓｐｒ­ｃａｓ 시스템 및 조성물의 전달，용도 및 치료적 적용
JP2022516647A (ja) 非毒性ｃａｓ９酵素およびその用途
JP2022512395A (ja) 分泌治療モダリティを送達するためのアネロソーム
CN113226336B (zh) 一种在细胞中递送基因的方法
WO2023193616A1 (zh) 单碱基编辑修复hba2基因突变的方法及其应用
JP2025516484A5 (https=)
WO2022109275A2 (en) Vectors, systems and methods for eukaryotic gene editing
JP2023550381A5 (https=)
EP4489772A1 (en) Compositions, systems and methods for eukaryotic gene editing
CN118715322A (zh) 酶、复合体、重组载体、遗传性疾病治疗药以及多核苷酸
JP2024534639A5 (https=)
CN121342932B (zh) 许氏平鲉内源性逆转录病毒包膜蛋白P_env、慢病毒载体及其应用
CN119161444B (zh) Lin28B基因上游开放阅读框编码的蛋白及其应用
WO2026067458A1 (en) Methods and compositions for tgfbi gene editing and therapy using crispr system and engineered protein delivery vehicle
WO2026067648A1 (en) Type ii cas protein and uses thereof
JPS62501049A (ja) 所定のポリペプチドまたは等価なポリペプチドを本来発現し得る一次細胞から得られた当該ポリペプチドを産生するハイブリツド細胞、当該ハイブリツド細胞の取得方法、および当該細胞の当該ポリペプチドの製造への応用
WO2026081151A1 (zh) 一种CRISPR介导的基因转录激活（CRISPRa）系统及其应用
WO2025149051A1 (zh) 腺嘌呤脱氨酶、包含其的碱基编辑器融合蛋白和碱基编辑器系统及其应用
Noothoven van Goor Advancing Mitochondrial Disorder Therapy: Virus-Like Particle Delivery of DdCBE Achieves Mitochondrial Genome Editing
WO2025096936A2 (en) Use of prime editing in correcting mutations in cdkl5
WO2023221938A1 (zh) 蛋白包裹自复制rna及其制备方法
EP4684009A1 (en) Improved methods and compositions for crispr interference and activation
CN121426972A (zh) 基于λN的基因编辑